There has been a fair degree of volatility in the Therapeutic Solutions International (OTCMKTS:TSOI) stock in the past days and on Monday, the stock started the week off by tanking by as much as 26% for the day. While the decline was alarming, it is also important to keep in mind that despite the drop, the stock is still up by as much as 25% for the past week.
Trading Data
On Monday, TSOI stock slumped 26.40% to $0.0265 with more than 27.18 million shares, compared to its average volume of 8.15 million shares. The stock moved within a range of $0.0241 – 0.0370 after opening trade at $0.0360.
Therapeutic Solutions International Announces ApoptoCyte Procedure for Enhancing Stem Cell Activity
In light of the selloff in the stock yesterday, it may be a good time to take a look at the announcement which led to it. The company came into focus after it published the data with regards to the novel procedure which could boost both anti-inflammatory as well as regenerative activities in the mesenchymal stem cells.
The findings were actually positive as it displayed that it helped in better therapeutic activity. While it goes without saying that the development was a significant one, it did not lead to any optimism among investors at all. In fact, the opposite happened as the stock tanked in a big way following the announcement. At this point in time, it is going to be interesting to see if the stock can actually recover.
Key Quote
“The conventional paradigm in regenerative medicine has been that mesenchymal stem cells produce growth factors, and for this they need to be alive,” said Dr. Thomas Ichim, Director of the Company. “Despite this, there have been some excellent studies showing that stem cells rapidly die when they contact blood, indicating the potential that therapeutic activity may be mediated by products released by dying stem cells. The ApoptoCyte procedure, which is applicable to all mesenchymal stem cells, involves induction of cellular suicide in the stem cell, extraction of small vesicles called “apoptotic bodies” and co-administration with specific drugs such as certain histone deacetylase (HDAC) inhibitors.”
Technical Data
TSOI stock is trading above the 20-Day and 50-Day Moving averages of $0.0235 and $0.0246 respectively. The stock is trading in oversold zone with the RSI at 54.
